News ArticlesNext Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian CancerOvarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30-50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have insufficient sensitivity and specificity for early detection and there is an urgent need to identify novel biomarkers...Read more Upcoming EventsFEBS Practical and Lecture CourseSeptember 11, 2022 - September 16, 2022FEBS Practical and Lecture Course - A summer school aimed at graduate students, post-docs, and young independent investigators who want to learn about new techniques to explore the proteins encoded by the human genome. News article |